Kannourakis G - Search Results

1

Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer.

Kadife E, Chan E, Luwor R, Kannourakis G, Findlay J, Ahmed N. Kadife E, et al. Among authors: kannourakis g. Cancers (Basel). 2019 Feb 19;11(2):243. doi: 10.3390/cancers11020243. Cancers (Basel). 2019. PMID: 30791462 Free PMC article.

2

Studies by radioiodination of normal adult, fetal and leukemic cell membranes.

Kannourakis G, Cauchi MN. Kannourakis G, et al. Exp Hematol. 1978 Sep;6(8):655-60. Exp Hematol. 1978. PMID: 361426

3

Osmotic fragility of leukaemic and normal lymphocytes.

Kannourakis G, Cauchi MN. Kannourakis G, et al. Pathology. 1978 Apr;10(2):131-4. doi: 10.3109/00313027809063490. Pathology. 1978. PMID: 277889

4

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.

Samardzija C, Luwor RB, Quinn MA, Kannourakis G, Findlay JK, Ahmed N. Samardzija C, et al. Among authors: kannourakis g. BMC Cancer. 2016 Jul 8;16:432. doi: 10.1186/s12885-016-2458-z. BMC Cancer. 2016. PMID: 27390927 Free PMC article.

5

Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells.

Ahmed N, Greening D, Samardzija C, Escalona RM, Chen M, Findlay JK, Kannourakis G. Ahmed N, et al. Among authors: kannourakis g. Sci Rep. 2016 Jul 29;6:30061. doi: 10.1038/srep30061. Sci Rep. 2016. PMID: 27470985 Free PMC article.

6

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling.

Samardzija C, Greening DW, Escalona R, Chen M, Bilandzic M, Luwor R, Kannourakis G, Findlay JK, Ahmed N. Samardzija C, et al. Among authors: kannourakis g. Sci Rep. 2017 Apr 13;7:46312. doi: 10.1038/srep46312. Sci Rep. 2017. PMID: 28406185 Free PMC article.

7

The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.

Escalona RM, Chan E, Kannourakis G, Findlay JK, Ahmed N. Escalona RM, et al. Among authors: kannourakis g. Int J Mol Sci. 2018 Feb 2;19(2):450. doi: 10.3390/ijms19020450. Int J Mol Sci. 2018. PMID: 29393911 Free PMC article. Review.

8

Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.

Chan E, Luwor R, Burns C, Kannourakis G, Findlay JK, Ahmed N. Chan E, et al. Among authors: kannourakis g. Oncotarget. 2018 Mar 30;9(24):16599-16618. doi: 10.18632/oncotarget.24615. eCollection 2018 Mar 30. Oncotarget. 2018. PMID: 29682172 Free PMC article.

9

Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.

Ahmed N, Escalona R, Leung D, Chan E, Kannourakis G. Ahmed N, et al. Among authors: kannourakis g. Semin Cancer Biol. 2018 Dec;53:265-281. doi: 10.1016/j.semcancer.2018.10.002. Epub 2018 Oct 11. Semin Cancer Biol. 2018. PMID: 30317036 Free article. Review.

10

Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods.

Ahmed N, Kadife E, Raza A, Short M, Jubinsky PT, Kannourakis G. Ahmed N, et al. Among authors: kannourakis g. Cells. 2020 Mar 14;9(3):719. doi: 10.3390/cells9030719. Cells. 2020. PMID: 32183385 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters